Audiologic Variability Among Patients Undergoing Cisplatin Treatment
Audiologic Variability Among Patients Undergoing Cisplatin Treatment
Member: $15.00
Nonmember: $20.00
SIG 06 Affiliate: $5.00
Add to Cart
Already in cart - Qty:


This course is included in the ASHA Learning Pass, which gives you unlimited access to our catalog of 750+ courses.

*If this is a recent SIG Perspectives course, you must also be a Special Interest Group (SIG) affiliate to unlock it as part of your subscription.

Learn more about the exceptional value of the ASHA Learning Pass

The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted

Learning Outcomes
You will be able to:

  • describe risk factors for cisplatin ototoxicity and the range of possible audiologic outcomes following cisplatin chemotherapy

Assessment Type
Self-assessment—Think about what you learned and report on the Completion Form how you will use your new knowledge.

Article in This Course

  1. A Tale of Two Susceptibilities: Cisplatin Ototoxicity by Variability in Similar Patients by Amy Custer, published in SIG 6, November 14, 2022

Continuing Education

11/10/2022 to 11/10/2027

Product Information

Item #(s): WEBS0620607
Client Age: Adults
Format(s): SIG Perspectives
Language: English

Already Purchased?